CONTEXT:  Commercial announcement of a collaboration on RWE generation in migraine.

IMPACT:  Low

READ TIME:  1 min

Quality Level Mean [1 – 10]:  6

1. “” Our ongoing partnership enables us to better understand our patient population, improve our offerings, and ultimately benefit the patients who suffer from migraine and the providers who care for these patients. “” 

2. “Advanced real-world evidence uses artificial intelligence-powered deep phenotyping and linked outcomes to understand disease progression and treatment effectiveness.” 

3. “” Through our multiple studies with Verantos, we have appreciated the firm’s scientific rigor and consistent delivery,” said Steve Kymes, Director, Health Economics and Outcomes Research at Lundbeck.” 

4. “The Verantos RWE platform integrates heterogenous real-world data sources and generates evidence with the accuracy necessary for regulatory and reimbursement use.” 

5. “About H. Lundbeck A/S Lundbeck is a global biopharmaceutical company specialized in brain diseases.” 

Source URL: https://www.prnewswire.com/news-releases/verantos-and-lundbeck-announce-partnership-for-migraine-care-implementing-advanced-real-world-evidence-rwe-301296007.html